• Therapeutic Cataract & Refractive
  • Lens Technology
  • Glasses
  • Ptosis
  • Comprehensive Eye Exams
  • AMD
  • COVID-19
  • DME
  • Ocular Surface Disease
  • Optic Relief
  • Geographic Atrophy
  • Cornea
  • Conjunctivitis
  • Myopia
  • Presbyopia
  • Allergy
  • Nutrition
  • Pediatrics
  • Retina
  • Cataract
  • Contact Lenses
  • Lid and Lash
  • Dry Eye
  • Glaucoma
  • Refractive Surgery
  • Comanagement
  • Blepharitis
  • OCT
  • Patient Care
  • Diabetic Eye Disease
  • Technology

Open-eye warm compress helps with efficacy, compliance


Ken DauSchmidt, founder and CEO of Tear Restore, Inc., shares information about TearResore Mask, the first open-eye warm compress treatment.


Ken DauSchmidt: Hello, my name is Ken DauSchmidt. I am the co-founder and CEO of TearRestore. We are here at Vision Expo West talking to thought leaders about everything new dry eye. We have got the first open open-eye warm compress available on the market today. It improves the efficacy of the treatment because the patient's blinking and naturally expressing the meibomian glands throughout. It also improves the compliance of the treatment because they can maintain their activity while they are doing their daily treatment. We have got a clinical study underway and we hope to share those results with you soon.

Related Videos
Megan Cavet, PhD
Nazlee Zebardast, MD, MSc, overviews her ARVO 2024 presentations on glaucoma and polygenic risk scores
Shelley Cutler, OD, FAAO, outlines her key takeaways from this year's IKA symposium
Edmund Tsui, MD, details what insights swept-source anterior segment OCT images may give to determining eye inflammation
Michael Chaglasian, OD, details success of new OCT device at the ARVO 2024 meeting
Emily Chew, MD, outlines her lecture that landed her the Proctor Award at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.